These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25194568)

  • 1. A new tumor suppressor role for the Notch pathway in bladder cancer.
    Rampias T; Vgenopoulou P; Avgeris M; Polyzos A; Stravodimos K; Valavanis C; Scorilas A; Klinakis A
    Nat Med; 2014 Oct; 20(10):1199-205. PubMed ID: 25194568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOTCH pathway inactivation promotes bladder cancer progression.
    Maraver A; Fernandez-Marcos PJ; Cash TP; Mendez-Pertuz M; Dueñas M; Maietta P; Martinelli P; Muñoz-Martin M; Martínez-Fernández M; Cañamero M; Roncador G; Martinez-Torrecuadrada JL; Grivas D; de la Pompa JL; Valencia A; Paramio JM; Real FX; Serrano M
    J Clin Invest; 2015 Feb; 125(2):824-30. PubMed ID: 25574842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canonical Notch signalling is inactive in urothelial carcinoma.
    Greife A; Jankowiak S; Steinbring J; Nikpour P; Niegisch G; Hoffmann MJ; Schulz WA
    BMC Cancer; 2014 Aug; 14():628. PubMed ID: 25167871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NOTCH pathway plays a tumor suppressive role in bladder cancer.
    Cancer Discov; 2014 Nov; 4(11):1252. PubMed ID: 25367939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4.
    Ai X; Jia Z; Liu S; Wang J; Zhang X
    Oncol Rep; 2014 Oct; 32(4):1459-64. PubMed ID: 25109409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder cancer and the Notch pathway.
    Fernandez-Marcos PJ; Serrano M; Maraver A
    Oncotarget; 2015 Jan; 6(3):1346-7. PubMed ID: 25633811
    [No Abstract]   [Full Text] [Related]  

  • 7. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
    Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of Disrupted Notch Signaling in Bladder Cancer.
    Greife A; Hoffmann MJ; Schulz WA
    Eur Urol; 2015 Jul; 68(1):3-4. PubMed ID: 25791514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling disparate roles of NOTCH in bladder cancer.
    Goriki A; Seiler R; Wyatt AW; Contreras-Sanz A; Bhat A; Matsubara A; Hayashi T; Black PC
    Nat Rev Urol; 2018 Jun; 15(6):345-357. PubMed ID: 29643502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer.
    di Martino E; Alder O; Hurst CD; Knowles MA
    Sci Rep; 2019 Apr; 9(1):5740. PubMed ID: 30952872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer.
    Schulz GB; Elezkurtaj S; Börding T; Schmidt EM; Elmasry M; Stief CG; Kirchner T; Karl A; Horst D
    Cancer Sci; 2021 May; 112(5):1987-1996. PubMed ID: 33686706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
    Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
    APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression.
    Swellam M; El-Aal AA; AbuGabel KM
    Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Notch play a tumor suppressor role across diverse squamous cell carcinomas?
    Zhang M; Biswas S; Qin X; Gong W; Deng W; Yu H
    Cancer Med; 2016 Aug; 5(8):2048-60. PubMed ID: 27228302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch controls urothelial integrity in the mouse bladder.
    Paraskevopoulou V; Bonis V; Dionellis VS; Paschalidis N; Melissa P; Chavdoula E; Vasilaki E; Pateras IS; Klinakis A
    JCI Insight; 2020 Feb; 5(3):. PubMed ID: 32051338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway.
    Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L
    Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.